The authors demonstrated the existence of a genomic group of IDH1/2 wild-type lower-grade gliomas (Group IV) lacking glioblastoma-like genomic aberrations such as 7q gains and 10q losses. The gene discussed is IDH1; the disease is glioblastoma.